Stock SNPX SYNAPTOGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Synaptogenix, Inc.

Equities

SNPX

US87167T3005

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-06-17 EDT 		5-day change 1st Jan Change
4.35 USD -5.64% Intraday chart for Synaptogenix, Inc. +4.57% -36.01%
05-15 Synaptogenix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-09 Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Synaptogenix, Inc. Announces Resignation of George Perry from the Board of Directors and as Member of All Committees of the Board
CI
Neurotrope Bioscience, Inc. has Changed its Name to Synaptogenix, Inc
CI
Neurotrope Bioscience, Inc. Appoints Paula T. Trzepacz as Executive Vice President and Chief Medical Officer
CI
Neurotrope Bioscience, Inc. Announces Resignation of Warren Wasiewski as Executive Vice President, Development
CI
Neurotrope Bioscience, Inc. Announces Executive Changes
CI
Neurotrope, Inc. and Neurotrope Bioscience, Inc. Announce Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNPX Stock
  4. News Synaptogenix, Inc.
  5. Insiders